Darmstadt, Germany, June 20 – Subsequent to the approval by the Annual General Meeting of Merck KGaA, Darmstadt, Germany on May 9, 2014 of a 1:2 share split, as of Monday, June 30, 2014, the listing of Merck KGaA, Darmstadt, Germany, shares (ISIN: DE0006599905, WKN: 659990) on the regulated market of the Frankfurt Stock Exchange (Prime Standard) will be changed.

The no-par-value shares with a pro rata amount of the share capital of € 2.60 will each be divided into two shares with a pro rata amount of the share capital of € 1.30 a piece. The price of a share will thereby be mathematically halved, with each shareholder then owning twice as many shares as before. Therefore, the share capital will not change.

Shares that are held in a securities account (collective securities accounts and possibly individual accounts), will be automatically converted; their owners do not need to take any action. Stock exchange orders that have not yet been executed, for example buy and sell limit orders, will expire after June 27, 2014 and need to be reissued.

The owners of paper share certificates (effective share certificates) will be asked to contact their financial institution.

The objective of the share split is to make Merck KGaA, Darmstadt, Germany, shares more attractive to all private investors. Thanks to the consistent implementation of the “Fit for 2018” transformation and growth program, the Merck KGaA, Darmstadt, Germany, share price has doubled over the past three years and has remained at well over € 100 for one year now.